Blood is a good growth medium for bacteria by preventing the accumulation of toxic oxygen (peroxide and superoxide) and increasing the growth ability of these bacteria. The purpose of this study was to evaluate the ability of lysed sheep blood and lysed cow blood as a substitute for lysed horse blood on Campylobacter growth media, as well as evaluate the growth of Campylobacter from chicken meat samples on culture media supplemented with lysed sheep blood and lysed cow blood compared to the media cultures using lysed horse blood supplements. The concentration of lysed sheep blood, lysed cow blood, and lysed horse blood used was 5% each. The chicken meat samples used in this study were 30 samples. Based on the results, 14 samples of C. jejuni bacteria showed the ability to grow up to 107 and 16 samples up to 106. In the media added with lysed cow blood supplement only one sample was able to grow up to 106, 17 samples grew up to 105, and 12 samples grew up to 104. These results statistically used the one way analysis of variance (ANOVA) test indicating a significant difference significant (P0.05). Further tests using post hoc least significance different (LSD) showed a comparison of the average growth in lysed horse blood, lysed sheep blood, and lysed cow blood significantly different (P 0.05), while the average value of each treatment was the addition of lysed horse blood supplements, lysed sheep blood, and cow blood consecutive lysis was 8.551 ± 0.340, 7.117 ± 0.544, and 5.265 ± 0.548. The addition of lysed sheep blood and lysed cow blood to bolton broth media in this study can be used for C. jejuni isolation. However, the blood of lysed sheep had a higher effectiveness in the ability to grow C. jejuni, which was close to the ability to grow with the addition of lysed horse blood as a control, compared to the addition of lysed cow blood.

The gut microbiota has a major contribution in human physiology and influences disease pathogenesis, including in tuberculosis (TB) lung infection. Gut-lung axis has demonstrated the interplay of these two organs, mediated by metabolites produced by the gut microbes or derived from host molecules transformation. Tryptophan (Trp) is one of the essential aromatic amino acids catabolized as kynurenine, serotonin (5-hydroxytryptamine), and indole derivatives, including indole propionic acid (IPA), via 3 pathways. The latter was microbiota-derived Trp catabolism, which has known to have an immunomodulatory role, as ligands for Aryl hydrocarbon Receptor (AhR). Intriguingly, Mycobacterium tuberculosis required Trp as a nitrogen source, especially in CD4+ T cells-generated stress, to survive in the phagosome of macrophage and to cause disease. Recently, IPA is identified as a new anti-mycobacterial compound, which is specific and has broad spectrum of anti-mycobacterial activity. The structural similarity of this gut microbiota-derived metabolite and Trp allows IPA to inhibit the TrpE anthranilate synthase in Trp biosynthesis pathway in Mtb. In this review, we summarize findings from recent work by focusing on the role of Trp metabolites in host cells in TB infection.  A better understanding of this chemical signal could potentially serve as a novel strategy for managing this chronic inflammatory disease.

Abortifacient pathogens such as bacterial [Brucella spp., Listeria spp., Leptospira interrogans ser., Coxiella burnetii, Campylobacter spp., Anaplasma spp., Chlamydia spp.], mycotic [Aspergillus spp. and Candida spp.], protozoan [Toxoplasma gondii, Neospora spp.], and viral [Blue tongue virus (BTV), Schmallenberg virus (SBV), Bovine viral diarrhea virus (BVDV), and Peste des petits ruminants virus (PPRV)] pathogens are challenges for the productive and reproductive performance of ruminants (cattle, sheep, and goats) globally. No comprehensive report on epidemiology, associated risk factors, or economic burden of these infectious pathogens is available for Nigeria. This review estimated the distribution and burden of abortive pathogens in ruminants in Nigeria for the last twenty-two years (2000-2022). Research articles reporting the detection of any of the above-mentioned abortive pathogens in ready-to-slaughter ruminants (RTSR), sick ruminants (SR), and ruminants with abortive history (RWAH) in Nigeria were accessed using different repositories, including Google Scholar, Proquest, PubMed, ResearchGate and Scopus to determine the prevalence, spatial distribution, and associated risk factors. From a total of 140 articles selected for this review, eight bacterial, four viral, two parasitic, and two mycotic infectious agents were reported for Nigeria. This study reveals a prevalence of 28.2% viral agents, 14.43% bacterial pathogens, 14.24% protozoans, and 28.1% fungal agents in the reported tested samples. Brucellosis was the most often reported among bacterial diseases, followed by leptospirosis and listeriosis. PPRV infection was the most common viral disease, followed by BTV. Additionally, two parasitic diseases, neosporosis and toxoplasmosis, and two mycotic diseases, aspergillosis and candidiasis, were reported. In this study, stillbirth and abortion were recorded in 49.2% of sheep with PPRV, 58.95% in goats with Chlamydophila abortus and PPRV, and 6.4% in cattle with Brucella abortus and Histophilus somni infections. Lack of vaccines, open markets, and extensive husbandry systems were among the risk factors associated with different abortive pathogens. This study is a useful tool for researchers and government officers in risk assessment and management of livestock to improve livestock production in Nigeria

intracellular pathogen Brucella and the free-living bacteria Ochrobactrum are both α-proteobacteria and very close to each other. A group of researchers recently clustered Ochrobactrum strains into the genus Brucella according to a BLAST distance approach. Thus, we performed a deeper comparative genetic analysis for eleven Ochrobactrum strains and twelve different Brucella isolates to demonstrate important differences between these bacteria. In addition to the clear differences between Brucella and Ochrobactrum, like the differences in genes contents, and different genome sizes, the Brucella-specific gene bscp31 was not found in Ochrobactrum, as well as other important Brucella-specific proteins and virulence factors. Differences in antimicrobial resistance genes content and the presence or absence of plasmids were obvious between Brucella and Ochrobactrum spp. Genome alignment of Brucella spp. and Ochrobactrum spp. revealed a genome similarity of 85.7% maximum, whereas all analyzed Brucella spp. in this study had a similarity of 97.6-99.9%, and all compared Ochrobactrum spp. 82.6-98.0%. Because of these facts mentioned in this work, Brucella and Ochrobactrum should be considered separate genera

Background: Brucellosis is an important infectious zoonotic disease caused by bacteria of the genus Brucella. It has global significance due to its adverse effects on public health, economics, and trade of animals and animal products. The causative agents of brucellosis, which have no plasmids or toxins and show distinctive virulence, are most significantly represented by intracellular survival. The commonly used antimicrobial drugs are not capable of entering the Brucella-infected cells that are safe from antibiotic treatment, but such treatments are only effective in the bacteremia phase of infection. Reports on the therapeutic management and cure of bovine brucellosis are limited in the literature. Therefore, an attempt was made to evaluate the combined oxytetracycline and streptomycin with benzylpenicillin injections in naturally Brucella-infected high-yielding dairy cross-breed cows. Objectives: This study was conducted to determine the sero-molecular prevalence and therapeutic responses of combined oxytetracycline and streptomycin with benzylpenicillin in naturally Brucella-infected dairy cross-bred cows. Materials and Methods: Serum samples of 460 (290 from Central Cattle Breeding and Dairy Farm, 170 from Military Dairy Farm, Savar, Dhaka) lactating cross-bred cows along with their milk samples were collected randomly. Serum samples were screened for brucellosis with the Rapid Antigen Kit Test, Rose Bengal Test (RBT), and Milk ring test (MRT), and positive samples were tested further with PCR for confirmatory diagnosis. Out of 11 all tests positive cows, of which three had a history of abortion were selected for therapeutic trials with combined long-acting oxytetracycline @ 25 mg/kg BW 3 doses at 24-hour intervals via intrauterine injection and streptomycin @ 20 mg/kg BW with benzylpenicillin @ 40,000 IU/kg 5 doses at 24 hours interval via intramuscular injections. Blood samples of all the Brucella-negative control and pre- and post-treatment stages of all the Brucella-infected cows were tested for Brucella by using PCR. Results: Out of 460 randomly collected serum samples, 18 serum samples 3.9% (95% CI 2.4-6.2) were found positive using RBT and Rapid Antigen Kit Test and 13 of the samples 2.8% (CI 1.5-4.9) were positive respectively. The overall seroprevalence was found to be 3.9% (95% CI 2.4-6.2) using RBT and Rapid Antigen Kit Test and 2.8% (CI 1.5-4.9) using Milk Ring Test, respectively. The odds of brucellosis were 7.4 times (95% CI: 2.5-21.5) higher in cows with repeat breeding than those without repeat breeding. Moreover, the seroprevalence of brucellosis was significantly higher (Odds ratio: 15.7; 95% CI: 5.2-47.4) in cows with retention of fetal membranes than without retention of fetal membranes. Base pair PCR 602. However, of the three treated cows, three became pregnant on artificial insemination with a normal reproductive cycle which needs to explore its status in further research. Conclusions: Combined antibiotic with oxytetracycline (I/U) and streptomycin with benzylpenicillin (I/M) against clinical Brucella infection showed some encouraging results and can be implemented at the field level.